Frequent detection of multidrug-resistant pneumonia-causing bacteria in the pneumonia lung tissues of patients with hematological malignancies

International Journal of Hematology

Volumn 86, Issue 3, 2007, Pages 225-232

  Inai, Kunihiro ^a,b   Iwasaki, Hiromichi ^a   Noriki, Sakon ^a   Ikegaya, Satoshi ^a   Yamashita, Masanori ^a   Imamura, Yoshiaki ^a   Takimoto, Nobuo ^a   Kato, Hisataka ^a   Ueda, Takanori ^a   Naiki, Hironobu ^a  

^a UNIVERSITY OF FUKUI   (Japan)

^b NONE   (Japan)

Author keywords

Autopsy; Hematological malignancy; Intrapulmonary sputum; Multidrug resistant bacteria; Pathology, pneumonia

Indexed keywords

AMPHOTERICIN B; AMPICILLIN; CEFOZOPRAN; CEFPIROME; CLINDAMYCIN; COTRIMOXAZOLE; FLEROXACIN; FLOMOXEF; FLUCONAZOLE; FOSFOMYCIN; GANCICLOVIR; HABEKACIN; IMIPENEM; ISEPAMICIN; ISONICOTINIC ACID; ITRACONAZOLE; LEVOFLOXACIN; MEROPENEM; METHYLPHENOBARBITAL; MINOCYCLINE; PANIPENEM; PENTAMIDINE; PIPERACILLIN; SPARFLOXACIN; SULPERAZON; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOPSY; BACTERIAL PNEUMONIA; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATION; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DISEASE COURSE; ENTEROCOCCUS FAECIUM; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; LUNG PARENCHYMA; LUNG RESECTION; MALE; MICROBIOLOGICAL EXAMINATION; PATHOGENESIS; SPUTUM ANALYSIS; STRAIN IDENTIFICATION; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; BACTERIA; BIOPSY; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; LUNG; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; SPUTUM;

EID: 36049034396     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.07233     Document Type: Article

References (30)

1. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309-317.
2. Hoban DJ, Biedenbach DJ, Mutnick AH, Jones RN. Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000). Diagn Microbiol Infect Dis. 2003;45:279-285.
3. Jones RN. Resistance patterns among nosocomial pathogens: trends over the past few years. Chest. 2001;119:397S-404S.
4. File TM, Jr. Overview of resistance in the 1990s. Chest. 1999;115: 3S-8S.
5. Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis. 2000;31:383-421.
6. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disc susceptibility tests; Approved Standard Eighth-edition, M2-A8. Philadelphia, PA; 2003.
7. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard Sixth-edition, M7-A6. Philadelphia, PA; 2003.
8. Haddadin AS, Fappiano SA, Lipsett PA. Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit. Postgrad Med J. 2002;78:385-392.
9. Tan L, Sun X, Zhu X, Zhang Z, Li J, Shu Q. Epidemiology of nosocomial pneumonia in infants after cardiac surgery. Chest. 2004;125:410-417.
10. Gordon S, Swenson JM, Hill BC, et al. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study Group. J Clin Microbiol. 1992;30:2373-2378.
11. Fluit AC, Jones ME, Schmitz FJ, Acar J, Gupta R, Verhoef J. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998. Clin Infect Dis. 2000;30:454-460.
12. Zumia A, Grange JM. Multidrug-resistant tuberculosis - can the tide be turned? Lancet Infect Dis. 2001;1:199-202.
13. Kaufmann SH. How can immunology contribute to the control of tuberculosis? Nat Rev Immunol. 2001;1:20-30.
14. Villari P, Sarnataro C, Iacuzio L. Molecular epidemiology of Staphylococcus epidermidis in a neonatal intensive care unit over a three-year period. J Clin Microbiol. 2000;38:1740-1746.
15. Kumar V, Abbas A, Fausto N. Rabbins and Cotran Pathologic Basis of Disease. Philadelphia, PA: Elsevier Saunders, 2004.
16. Maudsley J, Stone SP, Kibbler CC, Iliffe SR, Conaty SJ, Cookson BD, et al. The community prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in older people living in their own homes: implications for treatment, screening and surveillance in the UK. J Hosp Infect. 2004;57:258-262.
17. Lee NE, Taylor MM, Bancroft E, et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clin Infect Dis. 2005;40:1529-1534.
18. Timmers GJ, van der Zwet WC, Simoons-Smit IM, et al. Outbreak of vancomycin-resistant Enterococcus faecium in a haematology unit: risk factor assessment and successful control of the epidemic. Br J Haematol. 2002;116:826-833.
19. Peters RP, van Agtmael MA, Danner SA, Savelkoul PH, Vandenbroucke-Grauls CM. New developments in the diagnosis of blood-stream infections. Lancet Infect Dis. 2004;4:751-760.
20. Rahal JJ, Urban C, Segal-Maurer S. Nosocomial antibiotic resistance in multiple gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites. Clin Infect Dis. 2002;34:499-503.
21. Rice LB. Antimicrobial resistance in gram-positive bacteria. Amer J Infect Control. 2006;34:S11-19; discussion S64-73.
22. Matar MJ, Tarrand J, Raad I, Rolston KV. Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Amer J Infect Control. 2006;34:534-536.
23. Wade JC, Schimpff SC, Newman KA, Wiernik PH. Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia. Ann Intern Med. 1982;97: 503-508.
24. Horvathova Z, Spanik S, Sufliarsky J, et al. Bacteremia due to methicillin-resistant staphylococci occurs more frequently in neutropenic patients who received antimicrobial prophylaxis and is associated with higher mortality in comparison to methicillin-sensitive bacteriemia. Int J Antimicrob Agents. 1998;10:55-58.
25. Agvald-Ohman C, Lund B, Edlund C. Multiresistant coagulase-negative staphylococci disseminate frequently between intubated patients in a multidisciplinary intensive care unit. Crit Care. 2004;8:R42-47.
26. Sander A, Beiderlinden M, Schmid EN, Peters J. Clinical experience with quinupristin-dalfopristin as rescue treatment of critically ill patients infected with methicillin-resistant staphylococci. Intensive Care Med. 2002;28:1157-1160.
27. Dahmash NS, Chowdhury MN, Fayed DF. Coagulase-negative staphylococcal bacteraemia with special reference to septic shock: experience in an intensive care unit. J Infect. 1994;29:295-303.
28. Bone RC. The pathogenesis of sepsis. Ann Intern Med. 1991;115:457-469.
29. Miragaia M, Couto I, Pereira SF, et al. Molecular characterization of methicillin-resistant Staphylococcus epidermidis clones: evidence of geographic dissemination. J Clin Microbiol. 2002; 40:430-438.
30. Wielders CL, Vriens MR, Brisse S, et al. In-vivo transfer of mecA DNA to Staphylococcus aureus [corrected]. Lancet. 2001; 357:1674-1675.